Prosecution Insights
Prosecution Insights
Tech Center 1700 • Art Units: 1651 1657 1791
This examiner grants 32% of resolved cases
Tiffany Maureen Gough examines applications in Tech Center 1700, Art Unit 1651. With 522 resolved cases, she has an extensive history that includes an allowance rate of 31.6 percent. This rate indicates a rigorous examination process where applications face a high threshold for grant.
The interview lift is a significant 46.8 percent. This is one of the most impactful metrics in her profile, suggesting that interviews are highly effective at moving cases toward allowance. For practitioners facing a 31.6 percent baseline allowance rate, the lift provided by an interview makes direct communication an essential part of any prosecution strategy in Art Unit 1651.
The median time to allowance for Gough is 1655 days. This long pendency reflects the challenges of navigating Tech Center 1700. However, the data from 522 resolved cases clearly shows that while the process is slow and the baseline success rate is low, the 46.8 percent interview lift offers a powerful mechanism for applicants to improve their outcomes.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18606767 | GEL PRECURSOR COMPOSITION, METHOD FOR PRODUCING GEL, AND METHOD FOR ACTIVATING ENZYME | Non-Final OA | RICOH COMPANY, LTD. |
| 19416925 | AMYLASE COMPOSITIONS FOR PRODUCING COLLAGEN PEPTIDES AND METHODS OF FORMING COLLAGEN PEPTIDES | Non-Final OA | Rochal Technologies, LLC |
| 17998173 | METHODS AND COMPOSITIONS USING SERPIN PRODUCING BACTERIA | Non-Final OA | SOCIETE DES PRODUITS NESTLE S.A. |
| 18081147 | EVALUATION SYSTEM AND EVALUATION METHOD | Final Rejection | Hitachi, Ltd. |
| 18862887 | MEASUREMENT OF PERMEATION OF SMALL MOLECULES INTO GRAM NEGATIVE BACTERIA | Non-Final OA | University of Virginia Patent Foundation |
| 18978215 | PROBIOTIC COMPOSITIONS AND METHODS | Non-Final OA | UNIVERSITY OF OTTAWA |
| 17287619 | ENZYMES FOR INFUSION MASHING IN ADJUNCT BREWING TECHNICAL FIELD | Final Rejection | INTERNATIONAL N&H DENMARK APS |
| 17796018 | BLOOD-BRAIN-BARRIER SYSTEMS | Non-Final OA | B. G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD., AT BEN-GURION UNIVERSITY |
| 17789045 | LACTIC ACID BACTERIUM FERMENTATION PROMOTER | Non-Final OA | MEIJI CO., LTD. |
| 18285088 | PROCESS FOR BIOCONJUGATE PRODUCTION | Non-Final OA | GLAXOSMITHKLINE BIOLOGICALS S.A. |
| 18098422 | IDENTIFYING DIRECT ORAL FACTOR XA INHIBITORS | Non-Final OA | Instrumentation Laboratory Company |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy